ARCC-4 is a potent VHL-recruiting PROTAC that induces low-nanomolar degradation of the androgen receptor (DC50 = 5 nM). It outperforms enzalutamide and effectively targets clinically relevant AR mutants, making it a valuable tool for prostate cancer research in both cellular and in vivo models.
Molekulargewicht:
1024.18
CAS Nummer:
[1973403-00-7]
Formel:
C53H56F3N7O7S2
Target-Kategorie:
Androgen Receptor,PROTACs
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten